Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $513.2M |
| Sales growthchange from the year before | +27.4% |
| Gross marginshare of sales left after the direct cost of what it sells | 43.1% |
| Operating marginshare of sales left after running the business | 28.5% |
| Net marginshare of sales kept as profit | 22.5% |
| Free-cash-flow marginspare cash generated per $100 of sales | 36.4% |
| Return on invested capitalprofit made on each $100 put into the business | 10.0% |
| Return on equityprofit vs. shareholders' accounting value | 15.1% |
| Debt / equitydebt vs. shareholders' accounting value | 0.51 |
| Change in share countnegative = the company is buying back its shares | -0.7% |
No open-market buys or sells by its directors or officers in the last 90 days.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy